Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury

• Published in: Cancer chemotherapy and pharmacology 2024-10, Vol.94 (4), p.493-505
• Main Authors: Nguyen, Triet P. M., Woods, Susan L., Secombe, Kate R., Tang, Simon, Elz, Aurelia S., Ayton, Scott, Finnie, John, Nagpal, Aadya, Pouliot, Normand, Bowen, Joanne M.
• Format: Article
• Language: English
• Subjects: Adjuvants; Animals; Apoptosis; Breast cancer; Cancer Research; Cell death; Cell Line, Tumor; Colon; Colon - drug effects; Colon - metabolism; Colon - pathology; CRISPR; Diarrhea; Epidermal growth factor receptors; ErbB-2 protein; Female; Ferroptosis; Ferroptosis - drug effects; Glioblastoma; Glioma; Growth factor receptors; Histopathology; Humans; Kinases; Medical screening; Medicine; Medicine & Public Health; Metastases; Mice; Oncology; Original; Original Article; Pharmacology/Toxicology; Polymerase chain reaction; Protein Kinase Inhibitors - pharmacology; Quinolines - pharmacology; Rats; Rats, Wistar; Rodents; Toxicity; Tyrosine kinase inhibitors; Xenografts
• ISSN: 0344-5704; 1432-0843; 1432-0843
• DOI: 10.1007/s00280-024-04699-9

Purpose Neratinib, a small-molecule tyrosine kinase inhibitor (TKI) that irreversibly binds to human epidermal growth factor receptors 1, 2 and 4 (HER1/2/4), is an approved extended adjuvant therapy for patients with HER2 -amplified or -overexpressed ( HER2 -positive) breast cancers. Patients receiving neratinib may experience mild-to-severe symptoms of gut toxicity including abdominal pain and diarrhoea. Despite being a highly prevalent complication in gut health, the biological processes underlying neratinib-induced gut injury, especially in the colon, remains unclear. Methods Real-time quantitative polymerase chain reaction (RT-qPCR) and histology were integrated to study the effect of, and type of cell death induced by neratinib on colonic tissues collected from female Albino Wistar rats dosed with neratinib (50 mg/kg) daily for 28 days. Additionally, previously published bulk RNA-sequencing and CRISPR-screening datasets on human glioblastoma SF268 cell line and glioblastoma T895 xenograft, and mouse TBCP1 breast cancer cell line were leveraged to elucidate potential mechanisms of neratinib-induced cell death. Results The severity of colonic epithelial injury, especially degeneration of surface lining colonocytes and infiltration of immune cells, was more pronounced in the distal colon than the proximal colon. Sequencing showed that apoptotic gene signature was enriched in neratinib-treated SF268 cells while ferroptotic gene signature was enriched in neratinib-treated TBCP1 cells and T895 xenograft. However, we found that ferroptosis, but less likely apoptosis, was a potential histopathological feature underlying colonic injury in rats treated with neratinib. Conclusion Ferroptosis is a potential feature of neratinib-induced colonic injury and that targeting molecular machinery governing neratinib-induced ferroptosis may represent an attractive therapeutic approach to ameliorate symptoms of gut toxicity.